Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial.
暂无分享，去创建一个
D. Gudbjartsson | J. Gulcher | A. Kong | K. Stefánsson | H. Hakonarson | M. Gurney | E. Topol | A. Helgadóttir | D. Arnar | G. Thorgeirsson | A. Manolescu | K. Kristjánsson | F. Zink | A. Kristinsson | K. Andersen | M. Andrésdóttir | G. Thorgeirsson | A. E. Adalsteinsdottir | A. Sigurdsson | T. Hardarson | U. Agnarsson | Halldora Bjornsdottir | H. Gudmundsdóttir | G. Gottskálksson | Sverrir Thorvaldsson | Asgeir Jonsson | Atli Einarsson | K. Gudmundsson | Florian Zink | Asdis E Adalsteinsdottir